ANTG CRAFTS A PATHWAY TO PROFIT
What’s most important in business – purpose or profit? At ANTG we get to achieve both. Our revenue streams build business sustainability, allowing us to continue to focus on our passion for the plant and the people it can help. Our CEO, Matt Cantelo lays out our pathway to profits. Read the article here.
In conjunction with the HMRI and lead biomedical scientist Dr Matt Dun, we’re investigating the anticancer properties of our plant varieties. Dr Matt Dun shares his initial thoughts on the joint research project.
We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.
We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.LEARN ABOUT ANTG HERE >